{
    "applicationNumber": "BR 11 2021 003071-9",
    "filingDate": "22/08/2019",
    "grantDate": null,
    "title": "COMPOSI\u00c7\u00d5ES ESPECIALMENTE FORMULADAS DE NINTEDANIB E SAIS DE NINTEDANIB INALADOS",
    "nationalPhaseDate": [
        "19/02/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2019/047775",
        "pctDate": "22/08/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/721,522",
            "priorityDate": "22/08/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2617"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2627"
        },
        {
            "code": "6.23",
            "description": "Exig\u00eancia preliminar - pedidos com buscas realizadas por outros Escrit\u00f3rios de Patentes",
            "bulletinNumber ": "2735"
        }
    ],
    "inventors": [
        "MARK WILLIAM SURBER",
        "STEPHEN PHAM"
    ],
    "holders": [
        282729
    ],
    "ipcCodes": [
        "A61K 9/00",
        "C07D 209/34",
        "C07D 403/12"
    ]
}